Filing Details
- Accession Number:
- 0001209191-18-058039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-09 19:29:45
- Reporting Period:
- 2018-11-07
- Accepted Time:
- 2018-11-09 19:29:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
860730 | Hca Healthcare Inc. | HCA | Services-General Medical & Surgical Hospitals, Nec (8062) | 273865930 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632835 | S. Michael Cuffe | One Park Plaza Nashville TN 37203 | President-Physician Services | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-07 | 12,325 | $47.97 | 33,240 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-11-07 | 7,382 | $141.65 | 25,858 | No | 4 | F | Direct | |
Common Stock | Disposition | 2018-11-09 | 4,943 | $141.90 | 20,915 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Right | Disposition | 2018-11-07 | 12,325 | $0.00 | 12,325 | $47.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-02-05 | No | 4 | M | Direct |
Footnotes
- The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.